Bericht
Implementing pro-competitive criteria for the examination of pharmaceutical patents
This document discusses criteria for implementing the patentability requirements in relation to patent applications covering products and processes, as well as the use of pharmaceutical products. The adoption of rigorous criteria with this purpose is important for four main reasons.
- Language
-
Englisch
- Bibliographic citation
-
Series: Research Paper ; No. 64
- Classification
-
Sozialwissenschaften, Soziologie, Anthropologie
- Subject
-
Arzneimittel
Internationales Patentrecht
TRIPS
Welt
- Event
-
Geistige Schöpfung
- (who)
-
Correa, Carlos María
- Event
-
Veröffentlichung
- (who)
-
South Centre
- (where)
-
Geneva
- (when)
-
2016
- Handle
- Last update
-
10.03.2025, 11:45 AM CET
Data provider
This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
Object type
- Bericht
Associated
- Correa, Carlos María
- South Centre
Time of origin
- 2016
Other Objects (12)
Pharmaceutical innovation, incremental patenting and compulsory licensing
Implementing farmers' rights relating to seeds
The right to health in pharmaceutical patent disputes
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Implementing the Doha Declaration in OAPI legislation: Do transition periods matter?
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products: The case of Sri Lanka's patent law
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU: The need to rebalance
Manufacturing for export: A TRIPS-consistent pro-competitive exception
Rethinking Global Health: A Binding Convention for R&D for Pharmaceutical Products
Pharmaceutical innovation, incremental patenting and compulsory licensing
Implementing farmers' rights relating to seeds
The right to health in pharmaceutical patent disputes
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Implementing the Doha Declaration in OAPI legislation: Do transition periods matter?
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products: The case of Sri Lanka's patent law
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU: The need to rebalance
Manufacturing for export: A TRIPS-consistent pro-competitive exception
Rethinking Global Health: A Binding Convention for R&D for Pharmaceutical Products
Pharmaceutical innovation, incremental patenting and compulsory licensing
Implementing farmers' rights relating to seeds
The right to health in pharmaceutical patent disputes
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Implementing the Doha Declaration in OAPI legislation: Do transition periods matter?
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products: The case of Sri Lanka's patent law
Revisiting the question of extending the limits of protection of pharmaceutical patents and data outside the EU: The need to rebalance
Manufacturing for export: A TRIPS-consistent pro-competitive exception